A new nasal test may allow patients suspected of having lung cancer to undergo a simple swab of their nose to determine if they have the disease. Researchers at Boston University School of Medicine have found that a genomic biomarker in the nasal passage can accurately determine the likelihood of a lung lesion being malignant.